Lifecore Biomedical, Inc.

LFCR · NASDAQ
Analyze with AI
5/25/2025
5/26/2024
5/28/2023
5/29/2022
Operating Activities
Net Income-$39$12-$100-$117
Dep. & Amort.$8$8$13$18
Deferred Tax$0$0$0-$7
Stock-Based Comp.$10$6$4$3
Change in WC-$5-$4$20-$3
Other Non-Cash$25-$22$45$83
Operating Cash Flow-$0$0-$17-$23
Investing Activities
PP&E Inv.-$13-$18-$21-$30
Net Acquisitions$7$0$17$74
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$45
Other Inv. Act.$0$0$0-$9
Investing Cash Flow-$6-$18-$5$80
Financing Activities
Debt Repay.-$19$2$3-$55
Stock Issued$24$0$5$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$5$32-$2
Financing Cash Flow$6$8$40-$57
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$11$17$0
Supplemental Information
Beg. Cash$8$19$2$1
End Cash$8$8$19$2
Free Cash Flow-$14-$18-$39-$53
Lifecore Biomedical, Inc. (LFCR) Financial Statements & Key Stats | AlphaPilot